| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113762.1.4.1206.17 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.17 |
| version | 20200428 |
| status | active |
| publisher | Brigham and Women’s Hospital Steward |
| name | CoagulationDisorderConditions |
| title | Coagulation Disorder Conditions |
| date | 2020-04-28T01:00:20-04:00 |
| experimental | false |
| Usages | (none) |
This value set contains 31 concepts
| Code | System | Display |
| D61.09 | http://hl7.org/fhir/sid/icd-10-cm | Other constitutional aplastic anemia |
| D61.1 | http://hl7.org/fhir/sid/icd-10-cm | Drug-induced aplastic anemia |
| D61.3 | http://hl7.org/fhir/sid/icd-10-cm | Idiopathic aplastic anemia |
| D61.810 | http://hl7.org/fhir/sid/icd-10-cm | Antineoplastic chemotherapy induced pancytopenia |
| D61.811 | http://hl7.org/fhir/sid/icd-10-cm | Other drug-induced pancytopenia |
| D61.818 | http://hl7.org/fhir/sid/icd-10-cm | Other pancytopenia |
| D61.82 | http://hl7.org/fhir/sid/icd-10-cm | Myelophthisis |
| D61.89 | http://hl7.org/fhir/sid/icd-10-cm | Other specified aplastic anemias and other bone marrow failure syndromes |
| D61.9 | http://hl7.org/fhir/sid/icd-10-cm | Aplastic anemia, unspecified |
| D65 | http://hl7.org/fhir/sid/icd-10-cm | Disseminated intravascular coagulation [defibrination syndrome] |
| D66 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary factor VIII deficiency |
| D67 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary factor IX deficiency |
| D68.0 | http://hl7.org/fhir/sid/icd-10-cm | Von Willebrand disease |
| D68.1 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary factor XI deficiency |
| D68.2 | http://hl7.org/fhir/sid/icd-10-cm | Hereditary deficiency of other clotting factors |
| D68.311 | http://hl7.org/fhir/sid/icd-10-cm | Acquired hemophilia |
| D68.312 | http://hl7.org/fhir/sid/icd-10-cm | Antiphospholipid antibody with hemorrhagic disorder |
| D68.318 | http://hl7.org/fhir/sid/icd-10-cm | Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.32 | http://hl7.org/fhir/sid/icd-10-cm | Hemorrhagic disorder due to extrinsic circulating anticoagulants |
| D68.4 | http://hl7.org/fhir/sid/icd-10-cm | Acquired coagulation factor deficiency |
| D68.8 | http://hl7.org/fhir/sid/icd-10-cm | Other specified coagulation defects |
| D68.9 | http://hl7.org/fhir/sid/icd-10-cm | Coagulation defect, unspecified |
| D69.1 | http://hl7.org/fhir/sid/icd-10-cm | Qualitative platelet defects |
| D69.3 | http://hl7.org/fhir/sid/icd-10-cm | Immune thrombocytopenic purpura |
| D69.41 | http://hl7.org/fhir/sid/icd-10-cm | Evans syndrome |
| D69.42 | http://hl7.org/fhir/sid/icd-10-cm | Congenital and hereditary thrombocytopenia purpura |
| D69.49 | http://hl7.org/fhir/sid/icd-10-cm | Other primary thrombocytopenia |
| D69.51 | http://hl7.org/fhir/sid/icd-10-cm | Posttransfusion purpura |
| D69.6 | http://hl7.org/fhir/sid/icd-10-cm | Thrombocytopenia, unspecified |
| D69.8 | http://hl7.org/fhir/sid/icd-10-cm | Other specified hemorrhagic conditions |
| D69.9 | http://hl7.org/fhir/sid/icd-10-cm | Hemorrhagic condition, unspecified |
Produced 08 Sep 2023